Optimizing Amorphous Solid Dispersions: Overcoming Scale-Up Challenges with Next-Generation Technologies

As the number of poorly soluble molecules entering the pipeline has increased, the application of amorphous solid dispersions development has grown. With the advent of next-generation ASD technologies, like KinetiSol Technology, drug developers are setting new standards in scalability, sustainability and performance.

In this webinar, the expert speakers will share their scale-up experiences and perspectives on opportunities to improve technology transfers for amorphous solid dispersions. They will define best practices for a successful scale-up and a more complete and efficient tech transfer for the commercialization of amorphous solid dispersions.

Speakers:

Dr. Justin Keen, PhD, Senior Vice President, Operations, AustinPx
TJ Highley, MBA, CEO and Board Member, Microsize